Skip to content
10-Q

Quarterly Report

Tengjun Biotechnology Corp.

0001213900-23-067340

← back to feed
Filed
Aug 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 10, 2023 100.71M sh
Shares Diluted Q2 2023 · Jun 30, 2023 100.19M sh
Shares Diluted Q2 2023 · Jun 30, 2023 98.26M sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 $28.08M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $25.11M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $2.83M
Stockholders Equity Q2 2023 · Jun 30, 2023 $14.86M
Stockholders Equity Q2 2023 · Dec 31, 2022 $14.46M
Current Liabilities Q2 2023 · Jun 30, 2023 $423.7M
Current Liabilities Q2 2023 · Dec 31, 2022 $43.66M
Total Liabilities Q2 2023 · Jun 30, 2023 $423.7M
Total Liabilities Q2 2023 · Dec 31, 2022 $43.66M
Current Assets Q2 2023 · Jun 30, 2023 $430.5M
Current Assets Q2 2023 · Dec 31, 2022 $50.57M
Total Assets Q2 2023 · Jun 30, 2023 $438.96M
Total Assets Q2 2023 · Dec 31, 2022 $58.63M
Eps Diluted Q2 2023 · Jun 30, 2023 $0.00
Eps Diluted Q2 2023 · Jun 30, 2023 $0.00
Eps Basic Q2 2023 · Jun 30, 2023 $0.00
Eps Basic Q2 2023 · Jun 30, 2023 $0.00
Sga Expense Q2 2023 · Jun 30, 2023 $417.33K
Sga Expense Q2 2023 · Jun 30, 2023 $759.17K
Sga Expense Q2 2023 · Jun 30, 2022 $268.93K
Sga Expense Q2 2023 · Jun 30, 2022 $499.27K
Net Income Q2 2023 · Jun 30, 2023 −$453.11K
Net Income Q2 2023 · Jun 30, 2023 −$90.45K
Operating Income Q2 2023 · Jun 30, 2023 −$427.5K
Operating Income Q2 2023 · Jun 30, 2023 $148.48K
Gross Profit Q2 2023 · Jun 30, 2023 −$10.17K
Gross Profit Q2 2023 · Jun 30, 2023 $7.98M
Revenue Q2 2023 · Jun 30, 2023 $8.52M
Capex Q2 2023 · Jun 30, 2022 $4.97K